Nationwide FDA Recall on ReliOn Insulin Syringes

A press release from the FDA states that a nationwide recall of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles is in effect. The syringes are mislabeled and may result in patients receiving an overdose of as much as 2.5 times the intended dose of insulin. This could cause hypoglycemia, or possibly death.

Wal-Mart or Sam's Club pharmacies are the sole distributers of the ReliOn syringes. The recall applies only to lot number 813900. The product was distributed from Aug. 1, 2008 until Oct. 8, 2008, and includes 471,000 individual syringes in 4,710 boxes.

Please check syringe packaging carefully for products with this lot number. If you have these syringes do not use them. Return the product to the pharmacy for replacement syringes. The lot number can be found on the back panel of the 100 count syringe carton, or on the white paper backing of each individual syringe “peel-pack”.

Read the FDA press release here...

• FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes